Cargando…

Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer

A promising option as the treatment of choice for premenopausal patients with locally advanced or metastatic breast cancer (MBC) could be the combination of a luteinizing hormone-releasing hormone analog and an aromatase inhibitor. However, no prospective studies on the efficacy of goserelin with ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiayu, Xu, Binghe, Yuan, Peng, Ma, Fei, Li, Qing, Zhang, Pin, Cai, Ruigang, Fan, Ying, Luo, Yang, Li, Qiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	5600
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504532/ https://www.ncbi.nlm.nih.gov/pubmed/26131799 http://dx.doi.org/10.1097/MD.0000000000001006

Ejemplares similares

Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
por: Dixon, A. R., et al.
Publicado: (1990)

Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer
por: Gupta, Aanchal, et al.
Publicado: (2021)

Association between uterine leiomyoma and metabolic syndrome in parous premenopausal women: A case–control study
por: Tak, Young Jin, et al.
Publicado: (2016)

Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients
por: Jeon, Se Jeong, et al.
Publicado: (2016)

Uterine adhesion: Is luteal phase prior to follicular phase in uterine adhesiolysis?
por: Fei, Yilin, et al.
Publicado: (2021)

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer
por: Hackshaw, Allan, et al.
Publicado: (2009)

Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China
por: Li, Yiqun, et al.
Publicado: (2021)

Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies
por: Guan, Xiuwen, et al.
Publicado: (2023)

Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han population
por: Mo, Hongnan, et al.
Publicado: (2022)

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
por: Stein, R. C., et al.
Publicado: (1990)

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
por: Iaffaioli, R V, et al.
Publicado: (2005)

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
por: Iaffaioli, R V, et al.
Publicado: (2005)

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
por: Cheng, Tsui Fen, et al.
Publicado: (2012)

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer
por: Forward, D P, et al.
Publicado: (2004)

Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer: A phase 2, randomized controlled, prospective study
por: Guo, Qiufen, et al.
Publicado: (2020)

Estrogen Supplementation to Progesterone as Luteal Phase Support in Patients Undergoing In Vitro Fertilization: Systematic Review and Meta-Analysis
por: Zhang, Xiao-Mei, et al.
Publicado: (2015)

Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
por: Hasan, J, et al.
Publicado: (2005)

Successful treatment of locally advanced bulky cervical cancer complicated by irreducible complete uterine prolapse: A case report
por: Lee, Dong Hyung, et al.
Publicado: (2022)

Use of angiotensin II receptor blocker during pregnancy: A case report
por: Wei, Qiang, et al.
Publicado: (2021)

Predictive factors analysis of cesarean scar pregnancy treated by local injection of Lauromacrogol combined with curettage
por: Huang, Jianxia, et al.
Publicado: (2023)

Adverse impact of CD138+ cells in proliferative-phase endometrium on pregnancy outcomes in fresh IVF/ICSI cycles
por: Li, Jie, et al.
Publicado: (2023)

Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer
por: Zhao, Ke, et al.
Publicado: (2023)

Investigating the influence of primary uterine tumor site on pelvic and para-aortic lymph node metastatic pattern and evaluating the risk factors for lymph node metastases in endometrial carcinoma: A retrospective study
por: Zhang, Xiao, et al.
Publicado: (2023)

Recurrent and metastatic female adnexal tumor of probable Wolffian origin: A case report and review of the literature
por: Chen, Qiuhe, et al.
Publicado: (2021)

Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial
por: NISHIMURA, REIKI, et al.
Publicado: (2013)

Effects of sequential paclitaxel–carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study
por: Wang, Fei, et al.
Publicado: (2016)

Uterine artery embolization combined with local infusion of methotrexate and 5- fluorouracil in treating ectopic pregnancy: A CONSORT-compliant article
por: Gao, Juan, et al.
Publicado: (2018)

Sister Mary Joseph nodule as cutaneous manifestations of metastatic ovarian cancer: A case report and review of the literature
por: Nie, Xianglin, et al.
Publicado: (2022)

A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer.
por: Lind, M. J., et al.
Publicado: (1992)

Low FOXJ2 expression is associated with unfavorable postoperative prognosis of patients with epithelial ovarian cancer
por: Li, Yong, et al.
Publicado: (2021)

A Successfully Treated Metastatic Choriocarcinoma Coexistent With Pregnancy: A Case Report of a 4-Year Follow-Up
por: Yu, Panxi, et al.
Publicado: (2016)

Emergency obstetric hysterectomy for life-threatening postpartum hemorrhage: A 12-year review
por: Zhang, Yulong, et al.
Publicado: (2017)

Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis
por: Han, Yiqun, et al.
Publicado: (2019)

Phase I safety and pharmacokinetic study of cipatinib, an original dual tyrosine kinase inhibitor
por: Wang, Jiayu, et al.
Publicado: (2018)

Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial
por: Zhang, Pin, et al.
Publicado: (2016)

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
por: Lin, Shaoyan, et al.
Publicado: (2019)

Reproductive outcomes of ectopic pregnancy with conservative and surgical treatment: A systematic review and meta-analysis
por: Hao, Hong-Juan, et al.
Publicado: (2023)

Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial
por: Wang, Zijing, et al.
Publicado: (2021)

Clinical evaluation of improved MyoSure hysteroscopic tissue removal system for the resection of type II submucosal myomas
por: Liang, Yufei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bstkl2jm9tb5tise0omtce1kb5